Conformations of stereoisomeric base adducts to 4-Hydroxyequilenin

Chemical Research in Toxicology

Volumn 16, Issue 6, 2003, Pages 695-707

  Ding, Shuang ^a   Shapiro, Robert ^a   Geacintov, Nicholas E ^a   Broyde, Suse ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; 4 HYDROXYEQUILENIN; ADENINE; CATECHOL ESTROGEN; CONJUGATED ESTROGEN; CYTOSINE; DEOXYADENOSINE; DEOXYCYTIDINE; DNA BASE; DOUBLE STRANDED DNA; DRUG METABOLITE; EQUILENIN; EQUILIN; GUANINE; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; AUTOOXIDATION; CANCER RISK; CYTOTOXICITY; DENSITY FUNCTIONAL THEORY; DNA ADDUCT; DNA BINDING; DNA CONFORMATION; DNA REPAIR; DNA REPLICATION; ESTROGEN THERAPY; MATHEMATICAL COMPUTING; MOLECULAR STABILITY; MUTAGENICITY; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; THEORY;

EQUIDAE;

EID: 0037636061     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0340246     Document Type: Article

References (41)

1. Liehr, J. G. (1990) Genotoxic effects of estrogens. Mutat. Res. 238, 269-276.
2. Feigelson, H. S., and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279-2284.
3. Vogel, V. G., Yeomeans, A., and Higginbotham, E. (1993) Clinical management of women at increased risk for breast cancer. Breast Cancer Res. Treat. 28, 195-210.
4. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. (1995) Then use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl. J. Med. 332, 1589-1593.
5. Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., Hennekens, C. H., and Speizer, F. E. (1997) Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336, 1769-1775.
6. Li, J. J., Li, S. A., Oberley, T. D., and Parsons, J. A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res. 55, 4347-4351.
7. Lyman, G. W., and Johnson, R. N. (1982) Assay for conjugated estrogens in tablets using fused-silica capillary gas chromatography. J. Chromatogr. 234, 234-239.
8. Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S. (1998) Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 11, 1113-1127.
9. Chang, M., Zhang, F., Shen, L., Pauss, N., Alam, I., van Breemen, R. B., Blond-Elguindi, S., and Bolton, J. L. (1998) Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens. Chem. Res. Toxicol. 11, 758-765.
10. Zhang, F., Chen, Y., Pisha, E., Shen, L., Xiong, Y., van Breemen, R. B., and Bolton, J. L. (1999) The major metabolite of equilin, 4-hydroxyequilin autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol. 12, 204-213.
11. Bolton, J. L. (2002) Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology 177 (1), 55-65.
12. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135-160.
13. Service, R. F. (1998) New role for estrogen in cancer? Science 279, 1631-1633.
14. Yager, J. D., and Liehr, J. G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203-232.
15. Zhu, B. T., and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19, 1-27.
16. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E., Alam, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093-1101.
17. Chen, Y., Liu, X., Pisha, E., Constantinou, A. I., Hua, Y., Shen, L., van Breemen, R. B., Elguindi, E. C., Blond, S. Y., Zhang, F., and Bolton, J. L. (2000) A metabolite of equine estrogens, 4-hydroxyequilenin, induces DNA damage and apoptosis in breast cancer cell lines. Chem. Res. Toxicol. 13, 342-350.
18. Pisha, E., Lui, X., Constantinou, A. I., and Bolton, J. L. (2001) Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. Chem. Res. Toxicol. 14, 82-90.
19. Zhang, F., Swanson, S. M., van Breeman, R. B., Liu, X., Yang, Y., Gu, C., and Bolton, J. L. (2001) Equine estrogen metabolite 4-Hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem. Res. Toxicol. 14, 1654-1659.
20. Loechler, E. L. (1996) The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems. Carcinogenesis 17, 895-902.
21. Shen, L., Qiu, S., van Breemen, R. B., Zhang, F., Chen, Y., and Bolton, J. L. (1997) Reaction of the Premarin metabolite 4-hydroxyequilenin semiquinone radical with 2′-deoxyguanosine: formation of unusual cyclic adducts. J. Am. Chem. Soc. 119, 11126-11127.
22. Shen, L., Qiu, S., Chen, Y., Zhang, F., van Breemen, R. B., Nikolic, D., and Bolton, J. L. (1998) Alkylation of 2′-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical. Chem. Res. Toxicol. 11, 94-101.
23. Embrechts, J., Lemiere, F., Van Dongen, W., and Esmans, E. L. (2001) Equilenin-2′-deoxynucleoside adducts: analysis with nanoliquid chromatography coupled to nano-eletrospray tandem mass spectrometry. J. Mass Spectrom. 36, 317-328.
24. Yan, S., Min, W., Ding, S., Geacintov, N. E., and Broyde, S. (2002) Conformational analysis ofa 4-hydroxyequilenin guanine adduct using density function theory Chem. Res. Toxicol. 15, 648-653.
25. 5-3-ketosteroid isomerase from Pseudomonas testosteroni in complex with equilenin settles the correct hydrogen bonding scheme for transition state stabilization. J. Biol. Chem. 17, 32863-32868.
26. Halgren, T. A. (1996) Merck Molecular Force Field. I. Basis, Form, Scope, Parametrization and Performance of MMFF94. J. Comput. Chem. 17, 490-519.
27. Halgren, T. A. (1996) Merck Molecular Force Field. II. MMFF94 van der Waals and Electrostatic Parameters for Intermolecular Interactions. J. Comput. Chem. 17, 520-552.
28. Halgren, T. A. (1996) Merck Molecular Force Field. III. Molecular Geometrics and Vibrational Frequencies for MMFF94. J. Comput. Chem. 17, 553-586.
29. Halgren, T. A., and Nachbar, R. B. (1996) Merck Molecular Force Field. IV. Conformational Energies and Geometries. J. Comput. Chem. 17, 587-615.
30. Becke, A. D. (1993) Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 98, 5648-5652.
31. Becke, A. D. (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A 38, 3098-3100.
32. Lee, C., Yang, W., and Parr, R. G. (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 37, 785-789.
33. Vosko, S. H., Wilk, L., and Nusair, M. (1980) Accurate spindependent electron liquid correlation energies for local spin density calculations: a critical analysis. Can. J. Phys. 58, 1200-1211.
34. Frisch, J. M., Trucks, W. G., Schlegel, B. H., Scuseria, E. G., Robb, A. M., Cheeseman, R. J., Zakrzewski, G. V., Montgomery, A. J., Stratmann, E. R., Burant, C. J., Dappprich, S., Millam, M. J., Daniels, D. A., Kudin, N. K., Strain, C. M., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, A. G., Ayala, Y. P., Cui, Q., Morokuma, K., Malick, K. D., Rabuck, D. A., Raghavachari, K., Foresman, B. J., Cioslowski, J., Ortiz, V. J., Baboul, G. A., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Comperts, R., Martin, L. R., Fox, J. D., Keith, T., Al-Laham, A. M., Peng, Y. C., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, W. M. P., Johnson, B., Chen, W., Wong, W. M., Andres, L. J., Head-Gordon, M., Replogle, S. E., and Pople, A. J. (1998) Gaussian 98, revision A. 7, Gaussian, Inc., Pittsburgh, PA.
35. Johnson, F. (1968) Allylic strain in six-membered rings. Chem Rev. 68, 375-413.
36. Rabideau, P. W., Ed. (1989) Conformational Analysis of Cyclohexenes, Cyclohexadienes, and Related Hydroaromatic Compounds, VCH Publishers, New York.
37. Geacintov, N. E., Cosman, M., Hingerty, B. E., Amin, S., Broyde, S., and Patel, D. J. (1997) NMR solution structures of stereoisometric covalent polycyclic aromatic carcinogen-DNA adduct: principles, patterns, and diversity. Chem. Res. Toxicol. 10, 111-146.
38. Rechkoblit, O., Zhang, Y., Guo, D., Wang, Z., Amin, S., Krzeminsky, J., Louneva, N., and Geacintov, N. E. (2002) trans-Lesion synthesis past bulky benzo [a] pyrene diol epoxide N2-dG and N6-dA lesions catalyzed by DNA bypass polymerases. J. Biol. Chem. 277, 30488-30494.
39. Chiapperino, D., Kroth, H., Kramarczuk, I. H., Sayer, J. M., Masutani, C., Hanaoka, F., Jerina, D. M., and Cheh, A. M. (2002) Preferential misincorporation of purine nucleotides by human DNA polymerase eta opposite benzo[a]pyrene 7,8-diol 9,10-epoxide deoxyguanosine adducts. J. Biol. Chem. 277, 11765-11771.
40. Buterin, T., Hess, M. T., Luneva, N., Geacintov, N. E., Amin, S., Kroth, H., Seidel, A., and Naegeli, H. (2000) Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. Cancer Res. 60, 1849-1856.
41. Geacintov, N. E., Broyde, S., Buterin, T., Naegeli, H., Wu, M., Yan, S., and Patel, D. J. (2002) Thermodynamic and structural factors in the removal of bulky DNA adducts by the nucleotide excision repair machinery. Biopolymers 65, 202-210.